Remove Health Policy Remove Patient Experience Remove Pharmaceuticals
article thumbnail

What Person-Centered Interoperability Looks Like: Seqster

Health Populi

This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.

article thumbnail

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

The role of telehealth and remote patient monitoring in improving access to care. The challenges and opportunities of integrating social determinants of health into care delivery. Health Policy: The impact of healthcare policy on patient outcomes and access to care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Top Patient Safety Risks in 2025 Are Mostly About the “Human OS” – Reading ECRI’s Annual Report

Health Populi

Each year, ECRI (the ECRI Institute) publishes an annual report on the Top 10 Patient Safety Concerns for the year. The 2025 list was published today. My read of it is that most of these risks have to do with what I’ve been referring to as the Human OS, the Human Operating System, in my talks and teachings.

article thumbnail

Support for Drug Price Negotiation Brings Partisans Together in the U.S.

Health Populi

adults across political parties favor allowing the Federal government authority to negotiate for drug prices — even after hearing the arguments against the health policy. This patient experience crosses political parties in the U.S.,

Medicare 177
article thumbnail

The Home and Low-Touch Health Care – a Health Consumer Update from Capgemini

Health Populi

These trends point to more care being demanded by patients outside of the legacy care system, at home and via more virtual platforms. Capgemini offers recommendations to providers, pharmaceutical companies, and medical device manufacturers to tap opportunities outside of inpatient settings and, increasingly, to the home and digital device.

article thumbnail

Obesity is a Public Health Epidemic in the U.S. — The Case for GLP-1 Coverage, Affordability and Equity

Health Populi

These have been concerns raised about the health equity impacts of GLP-1s in the U.S., discussed recently: In Circulation in July 2024 In Lancet in June 2024 In Pharmaceutical Executive in March 2024 I n this essay on the Omada Health portal , and, In the Kaiser Family Foundation Health Tracking Poll conducted in May 2024.

article thumbnail

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them. consumers were asked.